Burlingame, CA, United States of America

Aibing Rao


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Aibing Rao: Innovator in Hepatotoxicity Assessment

Introduction

Aibing Rao is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of hepatotoxicity assessment through his innovative research and patented technologies. With a total of 2 patents, Rao's work focuses on improving the understanding of liver toxicity caused by various stimuli.

Latest Patents

Rao's latest patents include methods for predicting hepatotoxicity using cell-based assays. These assays are designed to assess the hepatotoxicity of different stimuli. Imaging technologies play a crucial role in analyzing the effects of these stimuli on hepatocytes. Through image analysis, the technology can characterize whether a stimulus is hepatotoxic and identify the type of pathology exhibited, such as apoptosis, necrosis, cholestasis, or steatosis.

Career Highlights

Aibing Rao is currently associated with Cytokinetics, Inc., where he continues to advance his research in hepatotoxicity. His work has garnered attention for its potential to enhance drug safety and efficacy by providing better predictive models for liver toxicity.

Collaborations

Rao collaborates with esteemed colleagues, including Larry C. Mattheakis and Jay Trautman. Their combined expertise contributes to the innovative research environment at Cytokinetics, Inc.

Conclusion

Aibing Rao's contributions to the field of hepatotoxicity assessment through his patented technologies highlight his role as a leading inventor. His work not only advances scientific understanding but also has the potential to improve drug safety in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…